Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: CHINA

Sector: Education and Training Services

Categories: @china   

iHuman Inc. is a childhood edutainment company. The Company offers products, digital content, and courses for children at various stages of development. iHuman serves students worldwide.


  • Bad financial results growth rate -18.3% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (-0.9%)
  • Dividend yield for the last twelve months 6.1%
  • Free cash flow yield -19.5% (LTM)
  • Share price is 3.7% higher than minimum and 59.5% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (500.0x vs 1.4x)
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: IH
Share price, USD:  (+1.4%)1.4
year average price 2.2469  


year start price 2.4250 2025-06-28

max close price 3.1700 2025-07-18

min close price 1.3500 2026-06-09

current price 1.4000 2026-06-27
Common stocks: 51 201 957

Dividend Yield:  6.1%
FCF Yield LTM: -19.5%
EV / LTM EBITDA: 500.0x
Last revenue growth (y/y):  -19.4%
Last growth of EBITDA (y/y):  -66.7%
Historical revenue growth:  -1.8%
Historical growth of EBITDA:  0.0%
EV / Sales: -0.7x
Margin (EBITDA LTM / Revenue): 8.7%

Target EV / EBITDA (hist percentile): 1.4x
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 72
Net Debt ($m): -157
EV (Enterprise Value): -85
EBITDA LTM (млн $): 11
EV / LTM EBITDA: 500.0x
Price to Book: 0.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-12-29prnewswire.com

iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

2025-11-25seekingalpha.com

iHuman: Undervalued With Geographical Expansion Upside

2025-09-18prnewswire.com

iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

2025-09-18prnewswire.com

iHuman and Cricket Media Team Up to Launch Reading Stars

2025-06-26prnewswire.com

iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results

2025-04-28prnewswire.com

iHuman Inc. Files 2024 Annual Report on Form 20-F

2025-03-25prnewswire.com

iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

2024-12-26prnewswire.com

iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

2024-09-27prnewswire.com

iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results

2024-06-28prnewswire.com

iHuman Inc. Announces First Quarter 2024 Unaudited Financial Results
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2025 q1 2024 q4 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol IH IH IH IH IH IH IH IH IH IH IH IH IH IH IH
reportedCurrency CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-09-30 2025-09-18 2025-03-31 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30
acceptedDate 2025-09-29 20:00:00 2025-09-18 07:08:02 2025-03-31 00:00:00 2025-04-28 16:01:23 2024-06-29 20:00:00 2024-03-30 20:00:00 2024-04-25 07:54:12 2023-09-29 20:00:00 2023-06-30 00:00:00 2023-03-31 07:40:06 2023-04-25 16:01:11 2022-09-29 20:00:00 2022-06-29 20:00:00 2022-04-29 16:19:46 2021-04-28 16:06:49
calendarYear 2025 2025 2025 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 205M 200M 210M 922M 215M 235M 1 018M 261M 241M 265M 986M 252M 231M 945M 532M
costOfRevenue 65M 64M 67M 282M 63M 67M 297M 75M 70M 80M 294M 74M 67M 284M 166M
grossProfit 140M 136M 144M 640M 152M 168M 721M 187M 171M 186M 691M 177M 163M 661M 365M
grossProfitRatio 0.683 0.678 0.683 0.705 0.715 0.714 0.709 0.7 0.704 0.708
researchAndDevelopmentExpenses 55M 53M 55M 248M 57M 68M 258M 66M 63M 62M 313M 72M 78M 415M 200M
generalAndAdministrativeExpenses 0 22M 26M 99M 24M 28M 104M 26M 26M 27M 109M 25M 29M 97M 115M
sellingAndMarketingExpenses 0 41M 41M 221M 51M 55M 200M 54M 41M 40M 157M 42M 34M 202M 96M
sellingGeneralAndAdministrativeExpenses 68M 63M 67M 320M 76M 83M 304M 80M 67M 67M 266M 67M 62M 300M 210M
otherExpenses 0 0 0 0 0 9M 0 20M 8M 6M 0 0 0 0 0
operatingExpenses 123M 116M 122M 568M 133M 151M 561M 146M 130M 129M 580M 139M 141M 715M 410M
costAndExpenses 188M 181M 189M 850M 196M 218M 858M 221M 200M 208M 874M 213M 208M 999M 576M
interestIncome 0 0 0 0 0 0 29M 0 0 0 12M 0 0 9M 0
interestExpense 0 0 0 0 0 0 0 0 0 -6M 0 -10M 0 0 0
depreciationAndAmortization 0 0 0 14M 0 3M 12M 3M 3M 0 11M 10M 0 6M 3M
ebitda 22M 19M 22M 86M 19M 17M 172M 40M 41M 57M 122M 39M 26M -48M -42M
ebitdaratio 0.107 0.097 0.103 0.088 0.074 0.154 0.17 0.214 0.153 0.111
operatingIncome 17M 19M 22M 72M 19M 17M 160M 40M 41M 57M 112M 29M 23M -54M -44M
operatingIncomeRatio 0.081 0.097 0.103 0.088 0.074 0.154 0.17 0.214 0.115 0.098
totalOtherIncomeExpensesNet 5M 15M 8M 39M 9M 9M 43M 20M 8M 6M 21M 19M 3M 17M 7M
incomeBeforeTax 22M 34M 30M 111M 28M 26M 203M 60M 49M 63M 133M 48M 26M -37M -37M
incomeBeforeTaxRatio 0.107 0.171 0.141 0.131 0.113 0.229 0.203 0.237 0.191 0.111
incomeTaxExpense 397 908 2M 3M 12M 4M 4M 22M 8M 7M 9M 23M 9M 4M -145 000 466 000
netIncome 21M 32M 27M 99M 25M 22M 181M 52M 42M 54M 110M 39M 22M -37M -37M
netIncomeRatio 0.105 0.159 0.126 0.115 0.095 0.199 0.175 0.202 0.157 0.094
eps 0 3.1 2.55 9.4 0.45 0.059 17.15 0.98 0.8 1.01 10.3 0.74 2.05 -3.45 -5.35
epsdiluted 0 3 2.45 0.45 0.057 0.95 0.77 0.99 0.73 2
weightedAverageShsOut 10M 10M 10M 10M 55M 53M 11M 53M 53M 53M 11M 53M 11M 11M 9M
weightedAverageShsOutDil 11M 11M 11M 11M 54M 55M 11M 55M 55M 54M 11M 54M 11M 11M 9M
link Link Link
finalLink Link Link
filingDate 2025-04-28 2024-04-25 2023-04-25 2022-04-29 2021-04-28
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 0 29M 12M 9M 0
ebit 72M 160M 112M -54M -44M
nonOperatingIncomeExcludingInterest 0 0 0 0 0
netIncomeFromContinuingOperations 99M 181M 110M -37M -37M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 99M 181M 110M -37M -48M
epsDiluted 9 16.5 10.15 -3.5 -5.35

Balance Sheet Statement

Property 2025 q3 2025 q2 2025 q1 2024 q4 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol IH IH IH IH IH IH IH IH IH IH IH IH IH IH IH
reportedCurrency CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-09-30 2025-09-18 2025-03-31 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30
acceptedDate 2025-09-29 20:00:00 2025-09-18 07:08:02 2025-03-31 00:00:00 2025-04-28 16:01:23 2024-06-29 20:00:00 2024-03-30 20:00:00 2024-04-25 07:54:12 2023-09-29 20:00:00 2023-06-30 00:00:00 2023-03-31 07:40:06 2023-04-25 16:01:11 2022-09-29 20:00:00 2022-06-29 20:00:00 2022-04-29 16:19:46 2021-04-28 16:06:49
calendarYear 2025 2025 2025 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 516M 605M 1 119M 1 123M 914M 891M 1 214M 1 038M 967M 924M 1 050M 879M 709M 855M 862M
shortTermInvestments 612M 495M 0 45M 215M 241M 0 136M 137M 110M 0 71M 148M 0 0
cashAndShortTermInvestments 1 128M 1 100M 1 119M 1 169M 1 129M 1 131M 1 214M 1 174M 1 105M 1 034M 1 050M 950M 856M 855M 862M
netReceivables 66M 58M 61M 54M 54M 71M 63M 71M 61M 83M 82M 80M 71M 59M 78M
inventory 20M 21M 19M 23M 19M 17M 17M 13M 15M 15M 19M 17M 24M 28M 17M
otherCurrentAssets 84M 85M 90M 69M 94M 94M 72M 84M 93M 104M 103M 94M 88M 73M 65M
totalCurrentAssets 1 299M 1 264M 1 289M 1 336M 1 297M 1 313M 1 382M 1 343M 1 273M 1 236M 1 254M 1 140M 1 039M 1 015M 1 021M
propertyPlantEquipmentNet 14M 15M 17M 18M 7M 9M 10M 11M 11M 17M 22M 27M 32M 51M 13M
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 17M 15M 16M 16M 20M 22M 23M 24M 25M 0 25M 0 0 27M 12M
goodwillAndIntangibleAssets 17M 15M 16M 16M 20M 22M 23M 24M 25M 23M 25M 27M 28M 27M 12M
longTermInvestments 26M 26M 26M 26M 26M 26M 26M 26M 26M 26M 26M 26M 26M 0 0
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 12M 15M 23M 23M 8M 8M 9M 8M 7M 6M 6M 4M 4M 8M 784 000
totalNonCurrentAssets 70M 71M 83M 84M 62M 65M 68M 69M 69M 72M 80M 84M 90M 86M 25M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 1 368M 1 335M 1 372M 1 420M 1 359M 1 378M 1 450M 1 412M 1 342M 1 308M 1 333M 1 225M 1 129M 1 101M 1 047M
accountPayables 27M 21M 24M 30M 20M 22M 22M 16M 20M 22M 24M 14M 20M 31M 22M
shortTermDebt 2M 2M 4M 0 2M 2M 0 2M 2M 2M 0 10M 15M 0 0
taxPayables 0 0 0 16M 0 0 29M 0 0 0 33M 0 0 20M 17M
deferredRevenue 230M 240M 268M 283M 290M 314M 0 320M 326M 362M 379M 341M 314M 303M 269M
otherCurrentLiabilities 116M 92M 125M 6M 137M 154M 356M 143M 114M 108M 5M 117M 109M 7M 3M
totalCurrentLiabilities 375M 356M 421M 448M 449M 491M 491M 481M 462M 493M 561M 482M 457M 483M 399M
longTermDebt 10M 10M 11M 0 1M 1M 0 2M 2M 3M 0 3M 3M 0 0
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalNonCurrentLiabilities 10M 10M 11M 11M 1M 1M 2M 2M 2M 3M 3M 3M 3M 10M 5M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 10M 12M 14M 15M 3M 3M 4M 4M 4M 4M 9M 14M 18M 34M 7M
totalLiabilities 385M 366M 431M 459M 450M 493M 493M 483M 464M 496M 564M 485M 461M 493M 404M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 186 038 185 000 185 000 185 000 185 000 185 000 185 000 185 000 185 000 185 000 185 000 185 000 185 000 185 000 184 000
retainedEarnings 38M 16M -16M -42M -93M -118M -140M -174M -225M -268M -321M -349M -388M -423M -386M
accumulatedOtherComprehensiveIncomeLoss 28M 31M 32M 32M 29M 27M 26M 32M 35M 12M 18M 20M -8M -35M -22M
othertotalStockholdersEquity 918M 922M 925M 974M 977M 1 070M 1 068M 1 068M 1 068M 1 065M
totalStockholdersEquity 983M 969M 941M 961M 909M 886M 958M 928M 878M 812M 769M 739M 669M 608M 643M
totalEquity 983M 969M 941M 961M 909M 886M 958M 928M 878M 812M 769M 739M 669M 608M 643M
totalLiabilitiesAndStockholdersEquity 1 368M 1 335M 1 372M 1 359M 1 378M 1 412M 1 342M 1 308M 1 225M 1 129M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 1 368M 1 335M 1 372M 1 420M 1 359M 1 378M 1 450M 1 412M 1 342M 1 308M 1 333M 1 225M 1 129M 1 101M 1 047M
totalInvestments 638M 521M 26M 72M 241M 267M 26M 163M 164M 136M 26M 97M 174M 0 0
totalDebt 12M 12M 14M 15M 3M 3M 4M 4M 4M 4M 9M 14M 18M 34M 7M
netDebt -505M -593M -1 105M -1 108M -912M -887M -1 210M -1 034M -964M -919M -1 041M -865M -691M -821M -855M
link Link Link
finalLink Link Link
filingDate 2025-04-28 2024-04-25 2023-04-25 2022-04-29 2021-04-28
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 52M 61M 82M 59M 78M
otherReceivables 2M 2M 0 0 0
prepaids 20M 17M 0 0 0
totalPayables 125M 22M 146M 131M 97M
otherPayables 94M 0 122M 100M 75M
accruedExpenses 30M 110M 24M 17M 29M
capitalLeaseObligationsCurrent 4M 2M 6M 25M 2M
capitalLeaseObligationsNonCurrent 11M 2M 3M 10M 5M
treasuryStock -26M -17M -7M -164 000 0
additionalPaidInCapital 997M 1 089M 1 079M 1 066M 1 050M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q2 2025 q1 2024 q4 2023 q4 2023 q3 2023 q2 2022 q4 2021 q4 2020 q4 2020 q3 2020 q2
date 2025-06-30 2025-03-31 2024-12-31 2023-12-31 2023-09-30 2023-06-30 2022-12-31 2021-12-31 2020-12-31 2020-09-30 2020-06-30
symbol IH IH IH IH IH IH IH IH IH IH IH
reportedCurrency CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-09-18 2025-03-31 2023-09-30 2023-03-31 2020-09-30 2020-06-30
acceptedDate 2025-09-18 07:08:02 2025-03-31 00:00:00 2025-04-28 16:01:23 2024-04-25 07:54:12 2023-09-28 20:00:00 2023-03-31 07:40:06 2023-04-25 16:01:11 2022-04-29 16:19:46 2021-04-28 16:06:49 2020-09-29 20:00:00 2020-06-29 20:00:00
calendarYear 2025 2025 2023 2023 2020 2020
period Q2 Q1 FY FY Q3 Q2 FY FY FY Q3 Q2
netIncome 32M 27M 99M 181M 52M 43M 752M -37M -37M 11M 7M
depreciationAndAmortization 0 0 14M 12M 0 0 74M 6M 3M 0 429 000
deferredIncomeTax 0 0 0 0 0 0 0 2M 1M 0 0
stockBasedCompensation 87 000 238 000 3M 9M 0 0 89M 15M 80M 0 0
changeInWorkingCapital 0 0 -59M 22M 0 0 178M 30M 165M 0 25M
accountsReceivables 0 0 9M 18M 0 0 -195M 22M -58M 0 -13M
inventory 0 0 -7M 3M 0 0 46M -13M 2M 0 0
accountsPayables 0 0 8M -2M 0 0 -43M 9M 11M 0 0
otherWorkingCapital 0 0 -68M 884 000 0 0 371M 12M 209M 0 0
otherNonCashItems -32M -27M 2M -52M -52M -43M 197M 22M 11M -11M -33M
netCashProvidedByOperatingActivities 0 0 59M 172M 0 0 1 291M 38M 223M 0 0
investmentsInPropertyPlantAndEquipment 0 0 -7M -7M 0 0 -45M -32M -16M 0 -4M
acquisitionsNet 0 0 0 0 0 0 0 0 0 0 0
purchasesOfInvestments 0 0 -252M -380M 0 0 -1 708M 0 0 0 0
salesMaturitiesOfInvestments 0 0 207M 380M 0 0 1 528M 0 0 0 0
otherInvestingActivites 0 0 0 0 0 0
netCashUsedForInvestingActivites 0 0 0 0 0 0
debtRepayment 0 0 0 0 0 0
commonStockIssued 0 0 0 0 0 0
commonStockRepurchased 0 0 -10M -10M 0 0 -7M -164 000 0 0 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites 0 0 0 0 0 -13M
netCashUsedProvidedByFinancingActivities 0 0 0 0 0 -13M
effectOfForexChangesOnCash 0 0 6M 8M 0 0 315M -13M -22M 0 0
netChangeInCash 0 0 -90M 164M 65M -9M 1 334M -6M 757M 0 25M
cashAtEndOfPeriod 0 0 1 123M 1 214M 1 038M 965M 7 195M 855M 862M 0 0
cashAtBeginningOfPeriod 0 0 1 214M 1 050M 973M 973M 5 861M 862M 105M 0 0
operatingCashFlow 0 0 59M 172M 0 0 1 291M 38M 223M 0 0
capitalExpenditure 0 0 -7M -7M 0 0 -45M -32M -16M 0 -4M
freeCashFlow 0 0 51M 166M 0 0 1 246M 6M 207M 0 0
link Link Link
finalLink Link Link
filingDate 2025-04-28 2024-04-25 2023-04-25 2022-04-29 2021-04-28
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 541 307 332 000 0
netCashProvidedByInvestingActivities -53M -7M -225M -32M -16M
netDebtIssuance 0 0 0 0 0
longTermNetDebtIssuance 0 0 0 0 0
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance -10M -10M -7M -164 000 630M
netCommonStockIssuance -10M -10M -7M -164 000 630M
commonStockIssuance 0 0 0 0 630M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -35M 0 0 0 -66M
commonDividendsPaid -35M 0 0 0 -66M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -57M 94 000 -41M 574 000 8M
netCashProvidedByFinancingActivities -102M -9M -48M 410 000 572M
incomeTaxesPaid 22M 23M 8M 459 000 15 000
interestPaid 0 0 0 0 0

Earning call transcript

Press-releases

Show financial reports only

2026-05-31 ET
iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
2026-04-24 20:23 ET
iHuman Inc. Files 2025 Annual Report on Form 20-F
2026-03-31 ET
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results
2025-12-29 ET
iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results
2025-11-24 ET
iHuman to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference
2025-09-18 08:30 ET
iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results
2025-09-18 ET
iHuman and Cricket Media Team Up to Launch Reading Stars
2025-06-26 ET
iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results
2025-04-28 ET
iHuman Inc. Files 2024 Annual Report on Form 20-F
2025-03-25 ET
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results
2024-12-26 ET
iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results
2024-09-27 09:47 ET
iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results
2024-06-28 04:01 ET
iHuman Inc. Announces First Quarter 2024 Unaudited Financial Results
2024-04-25 12:04 ET
iHuman Inc. Files 2023 Annual Report on Form 20-F
2024-02-29 05:01 ET
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results
2023-12-28 06:26 ET
iHuman Inc. Issues First Environmental, Social and Governance (ESG) Report
2023-12-28 06:12 ET
iHuman Inc. Announces Third Quarter 2023 Unaudited Financial Results
2023-11-02 12:35 ET
iHuman Inc. to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on November 9th 2023
2023-09-21 08:22 ET
iHuman Inc. Announces Second Quarter 2023 Unaudited Financial Results
2023-08-04 08:14 ET
iHuman's Vivien Wang Recognized as CFO of the Year 2022-2023
2023-06-21 04:01 ET
iHuman Inc. Announces First Quarter 2023 Unaudited Financial Results
2023-04-25 20:44 ET
iHuman Inc. Files 2022 Annual Report on Form 20-F
2023-03-31 04:43 ET
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results
2022-12-08 05:01 ET
iHuman Inc. Announces Third Quarter 2022 Unaudited Financial Results
2022-09-22 04:01 ET
iHuman Inc. Announces Second Quarter 2022 Unaudited Financial Results
2022-06-21 04:01 ET
iHuman Inc. Announces First Quarter 2022 Unaudited Financial Results
2022-04-29 21:14 ET
iHuman Inc. Files 2021 Annual Report on Form 20-F
2022-03-24 04:38 ET
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results
2021-12-21 10:17 ET
iHuman Inc. Announces Third Quarter 2021 Unaudited Financial Results and Share Repurchase Program
2021-09-29 11:48 ET
iHuman Inc. Announces Second Quarter 2021 Unaudited Financial Results
2021-06-08 05:47 ET
iHuman Inc. Announces First Quarter 2021 Unaudited Financial Results
2021-06-03 07:19 ET
iHuman Inc. to Report First Quarter 2021 Unaudited Financial Results on June 8, 2021
2021-05-17 12:35 ET
Deutsche Bank's Depositary Receipts Virtual Investor Conference
2021-04-28 20:23 ET
iHuman Inc. Files 2020 Annual Report on Form 20-F
2021-03-25 05:11 ET
iHuman Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results
2021-03-19 10:00 ET
iHuman Inc. to Report Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results on March 25, 2021
2020-12-02 05:22 ET
iHuman Inc. Announces Third Quarter 2020 Unaudited Financial Results
2020-11-24 13:28 ET
iHuman Inc. to Report Third Quarter 2020 Financial Results on December 2, 2020

SEC forms

Show financial reports only

SEC form 20
2026-04-24 20:02 ET
iHuman published news for 2026 q1
SEC form 20
2026-04-24 20:02 ET
iHuman published news for 2026 q1
SEC form 20
2026-04-24 20:02 ET
iHuman published news for 2026 q1
SEC form 20
2026-04-24 20:02 ET
iHuman published news for 2026 q1
SEC form 20
2026-04-24 20:02 ET
iHuman published news for 2026 q1
SEC form 20
2026-04-24 20:02 ET
iHuman published news for 2026 q1
SEC form 20
2026-04-24 20:02 ET
iHuman published news for 2026 q1
SEC form 20
2026-04-24 20:02 ET
iHuman published news for 2026 q1
SEC form 6
2026-03-31 12:19 ET
iHuman published news for 2025 q4
SEC form 6
2026-03-31 12:19 ET
iHuman published news for 2025 q4
SEC form 6
2025-12-29 12:33 ET
iHuman reported for 2025 q3
SEC form 6
2025-12-29 12:33 ET
iHuman published news for 2025 q3
SEC form 6
2025-09-18 11:08 ET
iHuman reported for 2025 q2
SEC form 6
2025-09-18 11:08 ET
iHuman published news for 2025 q2
SEC form 6
2025-06-26 11:54 ET
iHuman reported for 2025 q1
SEC form 6
2025-06-26 11:54 ET
iHuman published news for 2025 q1
SEC form 20
2025-04-28 00:00 ET
iHuman published news for 2025 q1
SEC form 20
2025-04-28 00:00 ET
iHuman published news for 2025 q1
SEC form 20
2025-04-28 00:00 ET
iHuman published news for 2025 q1
SEC form 20
2025-04-28 00:00 ET
iHuman published news for 2025 q1
SEC form 20
2025-04-28 00:00 ET
iHuman published news for 2025 q1
SEC form 20
2025-04-28 00:00 ET
iHuman published news for 2025 q1
SEC form 20
2025-04-28 00:00 ET
iHuman published news for 2025 q1
SEC form 20
2025-04-28 00:00 ET
iHuman published news for 2025 q1
SEC form 20
2025-04-28 00:00 ET
iHuman published news for 2025 q1
SEC form 6
2025-03-25 07:10 ET
iHuman published news for 2024 q4
SEC form 6
2025-03-25 07:10 ET
iHuman reported for 2024 q4
SEC form 6
2024-12-26 06:01 ET
iHuman published news for 2024 q3
SEC form 6
2024-12-26 06:01 ET
iHuman reported for 2024 q3
SEC form 6
2024-09-27 06:27 ET
iHuman published news for 2024 q2
SEC form 6
2024-09-27 06:27 ET
iHuman reported for 2024 q2
SEC form 6
2024-06-28 06:55 ET
iHuman reported for 2024 q1
SEC form 6
2024-06-28 06:55 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 20
2024-04-25 00:00 ET
iHuman published news for 2024 q1
SEC form 6
2024-02-29 06:28 ET
iHuman published news for 2023 q4
SEC form 6
2024-02-29 06:28 ET
iHuman reported for 2023 q4
SEC form 6
2023-12-28 06:03 ET
iHuman published news for 2023 q3
SEC form 6
2023-12-28 06:03 ET
iHuman published news for 2023 q3
SEC form 6
2023-09-21 06:19 ET
iHuman reported for 2023 q2
SEC form 6
2023-06-21 06:50 ET
iHuman reported for 2023 q1
SEC form 6
2023-04-25 16:03 ET
iHuman published news for 2023 q1
SEC form 6
2023-04-25 16:01 ET
iHuman published news for 2023 q1
SEC form 20
2023-04-25 00:00 ET
iHuman published news for 2023 q1
SEC form 6
2023-03-31 07:40 ET
iHuman reported for 2022 q4
SEC form 6
2022-12-08 06:01 ET
iHuman published news for 2022 q3
SEC form 6
2022-09-22 06:02 ET
iHuman published news for 2022 q2
SEC form 6
2022-06-21 06:05 ET
iHuman published news for 2022 q1
SEC form 6
2022-04-29 16:19 ET
iHuman published news for 2022 q1
SEC form 20
2022-04-29 00:00 ET
iHuman published news for 2022 q1
SEC form 6
2022-03-24 07:00 ET
iHuman published news for 2021 q4
SEC form 6
2021-12-21 08:10 ET
iHuman published news for 2021 q3
SEC form 6
2021-09-29 16:20 ET
iHuman published news for 2021 q2
SEC form 6
2021-09-29 08:35 ET
iHuman published news for 2021 q2
SEC form 6
2021-06-08 07:08 ET
iHuman published news for 2021 q1
SEC form 6
2021-04-28 16:06 ET
iHuman published news for 2021 q1
SEC form 20
2021-04-28 00:00 ET
iHuman published news for 2021 q1
SEC form 6
2021-03-25 07:30 ET
iHuman published news for 2020 q4
SEC form 6
2020-12-02 06:13 ET
iHuman published news for 2020 q3